{
  "id": 5853,
  "url": "https://nnemf.org/research/5853-extremely-low-frequency-electromagnetic-field-elf-emf-induced",
  "title": "Extremely low-frequency electromagnetic field (ELF-EMF) induced alterations in gene expression and cytokine secretion in clear cell renal carcinoma cells.",
  "authors": [
    "Aleksandra Cios",
    "Martyna Ciepielak",
    "Krystyna Lieto",
    "Damian Matak",
    "Sławomir Lewicki",
    "Małgorzata Palusińska",
    "Wanda Stankiewicz",
    "Łukasz Szymański"
  ],
  "journal": "Medycyna pracy",
  "year": "2024",
  "doi": "10.13075/mp.5893.01476",
  "pmid": "38717134",
  "abstract": "BACKGROUND: The study aimed to investigate the influence of extremely low-frequency electromagnetic fields (ELF-EMF) on clear cell renal cell carcinoma (ccRCC) by assessing alterations in gene expression and the secretion of cytokines and chemokines. MATERIAL AND METHODS: Three ccRCC cell lines (786-O, 769-P, and CAKI-1) and a healthy HEK293 cell line were subjected to ELF-EMF exposure (frequency 50 Hz, magnetic field strength 4.5 mT) for 30 min daily for 5 days. The study examined the expression of , , and genes, along with the secretion of 30 cytokines and chemokines. RESULTS: Notably, primary tumor-derived cell lines, but not those from metastatic sites, exhibited gene expression, which increased following ELF-EMF exposure. A statistically significant reduction in gene expression was observed in 769-P cells after ELF-EMF exposure. Additionally, gene expression was upregulated in HEK293, 769-P, and 786-O cells, representing normal embryonic kidney cells and primary tumor cells, but not in CAKI-1 cells, which model metastatic sites. After EMF exposure, there was a statistically significant decrease in transforming growth factor β1 (TGF-β1) concentration in the cell culture supernatants of HEK293 and CAKI-1 cell lines, with no other significant changes in the secretion of tested cytokines. CONCLUSIONS: Given the study's findings and available research, caution is warranted when drawing conclusions about the potential inhibitory effect of ELF-EMF on ccRCC progression. Standardization of experimental models is imperative when assessing the effects of EMF in a human context. Med Pr Work Health Saf. 2024;75(2):133-141.",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "Clear cell renal cell carcinoma (ccRCC) cell lines (786-O, 769-P, CAKI-1) and healthy HEK293 cell line",
    "sampleSize": "—",
    "exposure": "ELF · 0.00005 MHz · 30 min daily for 5 days",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Primary tumor-derived ccRCC cell lines (but not metastatic-derived) showed expression of a gene that increased after ELF-EMF exposure. A statistically significant reduction in another gene’s expression was observed in 769-P cells after exposure, while a third gene was upregulated in HEK293, 769-P, and 786-O but not in CAKI-1. After exposure, TGF-β1 concentration significantly decreased in HEK293 and CAKI-1 supernatants, with no other significant cytokine/chemokine secretion changes reported.",
    "outcomes": [
      "Gene expression changes (unspecified genes",
      "includes at least three genes assessed)",
      "Cytokine/chemokine secretion (30 analytes)",
      "TGF-β1 concentration in culture supernatant"
    ],
    "limitations": [
      "Specific gene names are not provided in the abstract (placeholders shown).",
      "In vitro cell-line model",
      "human health implications are uncertain.",
      "Exposure regimen limited to 50 Hz",
      "4.5 mT",
      "30 min/day for 5 days.",
      "Most cytokines/chemokines showed no significant changes",
      "findings may be limited in scope."
    ],
    "keywords": [
      "ELF-EMF",
      "50 Hz",
      "4.5 mT",
      "clear cell renal cell carcinoma",
      "ccRCC",
      "786-O",
      "769-P",
      "CAKI-1",
      "HEK293",
      "gene expression",
      "cytokines",
      "chemokines",
      "TGF-β1"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": null,\n    \"frequency_mhz\": 0.00005,\n    \"sar_wkg\": null,\n    \"duration\": \"30 min daily for 5 days\"\n  },\n  \"population\": \"Clear cell renal cell carcinoma (ccRCC) cell lines (786-O, 769-P, CAKI-1) and healthy HEK293 cell line\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Gene expression changes (unspecified genes; includes at least three genes assessed)\",\n    \"Cytokine/chemokine secretion (30 analytes)\",\n    \"TGF-β1 concentration in culture supernatant\"\n  ],\n  \"main_findings\": \"Primary tumor-derived ccRCC cell lines (but not metastatic-derived) showed expression of a gene that increased after ELF-EMF exposure. A statistically significant reduction in another gene’s expression was observed in 769-P cells after exposure, while a third gene was upregulated in HEK293, 769-P, and 786-O but not in CAKI-1. After exposure, TGF-β1 concentration significantly decreased in HEK293 and CAKI-1 supernatants, with no other significant cytokine/chemokine secretion changes reported.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"Specific gene names are not provided in the abstract (placeholders shown).\",\n    \"In vitro cell-line model; human health implications are uncertain.\",\n    \"Exposure regimen limited to 50 Hz, 4.5 mT, 30 min/day for 5 days.\",\n    \"Most cytokines/chemokines showed no significant changes; findings may be limited in scope.\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"ELF-EMF\",\n    \"50 Hz\",\n    \"4.5 mT\",\n    \"clear cell renal cell carcinoma\",\n    \"ccRCC\",\n    \"786-O\",\n    \"769-P\",\n    \"CAKI-1\",\n    \"HEK293\",\n    \"gene expression\",\n    \"cytokines\",\n    \"chemokines\",\n    \"TGF-β1\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/38717134/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5853",
  "updated": "2026-02-14 08:53:59"
}